Scribd Logo
Upload

Welcome to Scribd!

  • References

    Uploaded by

    Johanna Monroy
    4 views1 page
    Dyslipidemia is a high level of lipids in the blood such as high low-density lipoprotein (LDL) cholesterol or low high-density lipoprotein (HDL) cholesterol. Treatment options for gout include medications to reduce uric acid levels such as allopurinol and febuxostat. Peptic ulcer disease is caused by H. pylori infection or use of nonsteroidal anti-inflammatory drugs (NSAIDs) and treatment involves eradicating H. pylori and acid suppression therapy.

    Original Description:

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    Dyslipidemia is a high level of lipids in the blood such as high low-density lipoprotein (LDL) cholesterol or low high-density lipoprotein (HDL) cholesterol. Treatment options for gout include medications to reduce uric acid levels such as allopurinol and febuxostat. Peptic ulcer disease is caused by H. pylori infection or use of nonsteroidal anti-inflammatory drugs (NSAIDs) and treatment involves eradicating H. pylori and acid suppression therapy.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    4 views1 page

    References

    Uploaded by

    Johanna Monroy
    Dyslipidemia is a high level of lipids in the blood such as high low-density lipoprotein (LDL) cholesterol or low high-density lipoprotein (HDL) cholesterol. Treatment options for gout include medications to reduce uric acid levels such as allopurinol and febuxostat. Peptic ulcer disease is caused by H. pylori infection or use of nonsteroidal anti-inflammatory drugs (NSAIDs) and treatment involves eradicating H. pylori and acid suppression therapy.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Flag for inappropriate content
    of 1

    References:

    Davidson, M (2021). Dyslipidemia. Retrieved from


    https://www.msdmanuals.com/home/hormonal-and-metabolic-disorders/cholesterol-
    disorders/dyslipidemia#:~:text=Dyslipidemia%20is%20a%20high%20level,lipoprotein%20(HDL)
    %20cholesterol%20level.
    Engel, B., Just, J., & Weckbecker, K. (2017, March 31). Treatment Options for Gout. Retrieved
    from. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624445/#__ffn_sectitle
    Fashner, J., & Gitu, A. (2015, February 15). Diagnosis and treatment of peptic ulcer disease
    and H. pylori infection. American Family Physician. Retrieved February 11, 2022, from
    https://www.aafp.org/afp/2015/0215/p236.html
    Hainer, B., Matheson, E., & Wilkes, T. (2014, December 15). Diagnosis, Treatment, and Prevention
    of Gout. Retrieved from. https://www.aafp.org/afp/2014/1215/p831.html#sec-2
    Kamada, T., Satoh, K., & Itoh, T. (2021, April). Evidence-based clinical practice guidelines for
    peptic ulcer disease 2020. Journal of gastroenterology. Retrieved February 11, 2022, from
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005399/
    Kopin, L., & Lowenstein, C. (2017). Dyslipidemia. Annals of internal medicine, 167(11), ITC81–
    ITC96. https://doi.org/10.7326/AITC201712050
    Li, J., Pearlman, D., Nicklas, R., & Lowenthal, M. (2020). Algorithm for the diagnosis and
    management of asthma: a practice parameter update. Retrieved February 11, 2022, from
    https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Par
    ameters/rhinitis2008-diagnosis-management.pdf
    Pharmacotherapy: A Pathophysiologic Approach. Dipiro Et. al.
    National Heart, Lung and Blood Institute. (2020, December 3). 2020 focused updates to the
    Asthma Management Guidelines. National Heart Lung and Blood Institute. Retrieved February
    11, 2022, from https://www.nhlbi.nih.gov/health-topics/asthma-management-guidelines-2020-
    updates
    Zdanowicz, M. (2007, October 15). Pharmacotherapy of asthma. American journal of
    pharmaceutical education. Retrieved February 11, 2022, from
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2064896/?fbclid=IwAR3hvPVjarh71oKjZjtIJ4XU
    5la7YouH2oqZKi8-RZgz7Cl83TLObUjW2uo

    You might also like